As 2014 drew to a close yesterday evening, I watched the most stunning sunset along the Bushmans River Mouth in the Eastern Cape (South Africa).  Incredible colours in the sky, reflected along the river; I could feel the trauma of the past 6 months drift away, out to the Indian Ocean, along with the tide.... Continue Reading →

BOT-affected advice/input to develop factsheet to support our engagement with the health system

From discussions in the Facebook group, it is clear that those of us who have had a BOT diagnosis have some important experiences and insights about engagement with healthcare providers and the healthcare system when undergoing a diagnosis, treatment and monitoring for BOT.  These insights would be very helpful to others including BOT-ladies, their families... Continue Reading →

BOTs: aggressiveness and monitoring

Good article. Borderline ovarian tumors (BOTs) were first described as a separate group in 1929 by Taylor [1] , but only in 1973, they were accepted by the International Federation of gynecology and Obstetrics (FIGO) as carcinomas of low malignant potential [2] and from 1973 by the World Health Organization (WHO) as ‘borderline ovarian tumors’ [3] , the... Continue Reading →

Borderline ovarian tumour is a useful and helpful terminology that should be retained. Presence of a micropapillary pattern is not associated with a more aggressive tumour/worse outcome. W Glenn McCluggage DIAGNOSTIC HISTOPATHOLOGY 20:9 2014 Abstract Ovarian borderline tumours are relatively uncommon but not rare neoplasms. A large majority are of serous or mucinous type with other morphological... Continue Reading →

Create a free website or blog at WordPress.com.

Up ↑